268 related articles for article (PubMed ID: 8626860)
1. Antiprogestin and/or gonadotropin-releasing hormone agonist for endometriosis treatment and bone maintenance: a 1-year primate study.
Grow DR; Williams RF; Hsiu JG; Hodgen GD
J Clin Endocrinol Metab; 1996 May; 81(5):1933-9. PubMed ID: 8626860
[TBL] [Abstract][Full Text] [Related]
2. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
[TBL] [Abstract][Full Text] [Related]
3. Emerging drugs for endometriosis.
Fedele L; Berlanda N
Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
[TBL] [Abstract][Full Text] [Related]
4. Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy.
Surrey ES; Voigt B; Fournet N; Judd HL
Fertil Steril; 1995 Apr; 63(4):747-55. PubMed ID: 7890057
[TBL] [Abstract][Full Text] [Related]
5. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone agonist reduces aromatase cytochrome P450 and cyclooxygenase-2 in ovarian endometrioma and eutopic endometrium of patients with endometriosis.
Kim YA; Kim MR; Lee JH; Kim JY; Hwang KJ; Kim HS; Lee ES
Gynecol Obstet Invest; 2009; 68(2):73-81. PubMed ID: 19401614
[TBL] [Abstract][Full Text] [Related]
7. Treatment of endometriosis in monkeys: effectiveness of continuous infusion of a gonadotropin-releasing hormone agonist compared to treatment with a progestational steroid.
Mann DR; Collins DC; Smith MM; Kessler MJ; Gould KG
J Clin Endocrinol Metab; 1986 Dec; 63(6):1277-83. PubMed ID: 3097054
[TBL] [Abstract][Full Text] [Related]
8. Chronic antiprogestin therapy produces a stable atrophic endometrium with decreased fibroblast growth factor: a 1-year primate study on contraception and amenorrhea.
Grow DR; Reece MT; Hsiu JG; Adams L; Newcomb PM; Williams RF; Hodgen GD
Fertil Steril; 1998 May; 69(5):936-43. PubMed ID: 9591506
[TBL] [Abstract][Full Text] [Related]
9. [Clinical efficacy and safety of gonadotropin releasing hormone agonist combined with estrogen-dydrogesteronea in treatment of endometriosis].
Long QQ; Zhang SF; Han Y; Chen H; Li XL; Hua KQ; Hu WG
Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):247-51. PubMed ID: 20646533
[TBL] [Abstract][Full Text] [Related]
10. Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486).
Kettel LM; Murphy AA; Morales AJ; Yen SS
Am J Obstet Gynecol; 1998 Jun; 178(6):1151-6. PubMed ID: 9662295
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-releasing hormone agonist suppresses ovulation, menses, and endometriosis in monkeys: an individualized, intermittent regimen.
Werlin LB; Hodgen GD
J Clin Endocrinol Metab; 1983 Apr; 56(4):844-8. PubMed ID: 6403565
[TBL] [Abstract][Full Text] [Related]
12. Effect of gonadotropin-releasing hormone agonists, nafarelin, buserelin, and leuprolide, on experimentally induced endometriosis in the rat.
Mizutani T; Sakata M; Terakawa N
Int J Fertil Menopausal Stud; 1995; 40(2):106-11. PubMed ID: 7599657
[TBL] [Abstract][Full Text] [Related]
13. Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome.
Mitwally MF; Gotlieb L; Casper RF
Menopause; 2002; 9(4):236-41. PubMed ID: 12082359
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone analogue plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial.
Gregoriou O; Konidaris S; Vitoratos N; Papadias C; Papoulias I; Chryssicopoulos A
Int J Fertil Womens Med; 1997; 42(6):406-11. PubMed ID: 9459084
[TBL] [Abstract][Full Text] [Related]
15. [Studies on endocrine therapy of endometriosis].
Terakawa N
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Aug; 41(8):981-9; discussion 1000-7. PubMed ID: 2530291
[TBL] [Abstract][Full Text] [Related]
16. [Effects and safety of gonadotrophin-releasing hormone agonist combined with estradiol patch and oral medroxyprogesterone acetate on endometriosis].
Wang YQ; Zhang SF; Chen X; Zhu J; Hua KQ; Hu WG
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):504-8. PubMed ID: 19957549
[TBL] [Abstract][Full Text] [Related]
17. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
[TBL] [Abstract][Full Text] [Related]
18. Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group.
Hornstein MD; Surrey ES; Weisberg GW; Casino LA
Obstet Gynecol; 1998 Jan; 91(1):16-24. PubMed ID: 9464714
[TBL] [Abstract][Full Text] [Related]
19. [Mifepristone following conservative surgery in the treatment of endometriosis].
Jiang J; Lu J; Wu R
Zhonghua Fu Chan Ke Za Zhi; 2001 Dec; 36(12):717-20. PubMed ID: 16136889
[TBL] [Abstract][Full Text] [Related]
20. RU486: pharmacology and potential use in the treatment of endometriosis and leiomyomata uteri.
Murphy AA; Castellano PZ
Curr Opin Obstet Gynecol; 1994 Jun; 6(3):269-78. PubMed ID: 8038415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
